Keyphrases
Virus
100%
Host Range
100%
Intranasal Immunization
100%
Emerging Pathogen
100%
Severe Acute Respiratory Syndrome-associated Coronavirus
100%
Vaccine Vector
100%
Newcastle Disease Virus
100%
Range Limits
100%
Titer
28%
Viral Replication
14%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
14%
Protective Antigen
14%
Human Vaccines
14%
Vaccine Development
14%
Transcription Unit
14%
Rapid Response
14%
Further Development
14%
Lung Tissue
14%
High Dose
14%
Respiratory Tract
14%
African Green Monkey
14%
Primates
14%
Neutralizing Antibodies
14%
Intranasal
14%
Necropsy
14%
Secondary Response
14%
Two-dose
14%
Pre-existing Immunity
14%
Virus Neutralization
14%
Coronavirus Spike Protein
14%
Coronavirus Vaccine
14%
Avian Paramyxovirus
14%
Mean Reduction
14%
Spike Glycoprotein
14%
Newcastle Disease Vaccine
14%
Recombinant Newcastle Disease Virus
14%
Respiratory Vaccine
14%
Viral Assay
14%
Immunology and Microbiology
Infectious Agent
100%
Coronavirinae
100%
Severe Acute Respiratory Syndrome
100%
Host Range
100%
Newcastle Disease Virus
100%
Titer
28%
SARS Coronavirus
14%
Viral Replication
14%
Glycoprotein
14%
Neutralization
14%
Drug Megadose
14%
Neutralizing Antibody
14%
Chlorocebus Aethiops
14%
Viral Vector
14%
Spike
14%
Avulavirus
14%